Clinical and cell kinetic studies of the effects of the epipodophyllotoxin VP16-213 during therapy of refractory acute nonlymphocytic leukemia.
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D001374:Azacitidine / Q000627:therapeutic use; D002455:Cell Division / Q000187:drug effects*; D002648:Child; D002675:Child, Preschool; D004273:DNA, Neoplasm / Q000378:metabolism; D004351:Drug Resistance; D005047:Etoposide / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D007223:Infant; D007700:Kinetics; D007938:Leukemia / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008938:Mitosis / Q000187:drug effects; D011034:Podophyllotoxin / Q000031:analogs & derivatives*
D004273:DNA, Neoplasm; D005047:Etoposide; D011034:Podophyllotoxin; D001374:Azacitidine